ストックスクリーナーアプリを入手
1.52
3.85%
-0.04
前日終値:
$1.56
開ける：
$1.59
24時間の取引高:
224.49K
Relative Volume:
2.29
時価総額：
$25.78M
収益：
$48.43M
当期純損益:
$-11.04M
株価収益率:
-2.2687
EPS:
-0.67
ネットキャッシュフロー:
$-7.00M
1週間 パフォーマンス:
+1.35%
1か月 パフォーマンス:
+21.95%
6か月 パフォーマンス:
+6.38%
1年 パフォーマンス:
-8.22%
1日の値動き範囲:
$1.46
$1.59
1週間の範囲:
$1.42
$1.6481
52週間の値動き範囲:
$0.782
$1.70
Iridex Corp Stock (IRIX) Company Profile
IRIX を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
IRIX
Iridex Corp
|
1.50 | 26.82M | 48.43M | -11.04M | -7.00M | -0.67 |
|
ABT
Abbott Laboratories
|
107.41 | 189.14B | 44.33B | 6.48B | 6.92B | 3.7033 |
|
BSX
Boston Scientific Corp
|
93.50 | 138.74B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
355.79 | 136.52B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
101.23 | 129.06B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
83.73 | 48.90B | 5.88B | 1.34B | 799.60M | 2.3489 |
Iridex Corp Stock (IRIX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2017-11-03 | 再開されました | ROTH Capital | Buy |
| 2016-12-21 | 開始されました | ROTH Capital | Buy |
| 2016-01-26 | 開始されました | Singular Research | Buy |
| 2007-01-03 | 開始されました | First Albany | Buy |
Iridex Corp (IRIX) 最新ニュース
Iridex CFO Dizon buys $5k in IRIX stock By Investing.com - Investing.com India
Moving Averages: Is IRIDEX Corporation backed by strong institutional buying2025 Market Sentiment & Weekly High Momentum Picks - baoquankhu1.vn
Insider Buying: Romeo Dizon Acquires Additional Shares of IRIDEX Corp (IRIX) - GuruFocus
Iridex CFO Dizon buys $1.8k in IRIX stock By Investing.com - Investing.com India
Iridex CFO Dizon buys $1.8k in IRIX stock - Investing.com
Iridex CFO Dizon buys $7.7k in company stock By Investing.com - Investing.com India
Iridex CFO Dizon buys $7.7k in company stock - Investing.com
Iridex CFO Dizon buys shares worth $6.3k By Investing.com - Investing.com Nigeria
Iridex CFO Dizon buys shares worth $6.3k - Investing.com
Iridex reports 15-17% revenue growth in Q4, achieves positive cash flow - Investing.com
IRIX Projects Significant Revenue Growth with Strategic Initiati - GuruFocus
Iridex Announces Preliminary Operational and Financial Results for Fourth Quarter and Full Year 2025 - marketscreener.com
Medical laser maker for glaucoma care turns cash positive after growth push - Stock Titan
Can IRIDEX Corporation stock hit record highs again2025 Market Sentiment & Stock Timing and Entry Methods - ulpravda.ru
IRIDEX Corp: Can This Beaten-Down Ophthalmic Stock Still See The Light? - AD HOC NEWS
IRIDEX (NASDAQ:IRIX) Shares Cross Below 200-Day Moving Average – What’s Next? - Defense World
IRIX SEC FilingsIridex 10-K, 10-Q, 8-K Forms - Stock Titan
Is IRIDEX Corporation stock a top momentum playJuly 2025 Macro Moves & Daily Stock Momentum Reports - Улправда
Published on: 2025-12-19 17:58:41 - Улправда
What margin trends mean for IRIDEX Corporation stockJuly 2025 Catalysts & Reliable Volume Spike Trade Alerts - Улправда
[Form 4] IRIDEX CORP Insider Trading Activity - Stock Titan
Why retail investors pile into IRIDEX Corporation stockRisk Management & High Conviction Investment Ideas - Улправда
IRIDEX (IRIX) director William Moore reports 20,000-share stock purchase - Stock Titan
Iridex CFO Dizon buys $2296 in company stock By Investing.com - Investing.com Nigeria
I’ve reviewed the SEC filing and prepared the following news article - Investing.com UK
Dir Moore Buys 30,000 ($28.5K) Of IRIDEX Corp [IRIX] - TradingView — Track All Markets
Iridex CFO Dizon buys $2296 in company stock - Investing.com
IRIDEX Corporation (NASDAQ: IRIX) presents at Sidoti Year-End Virtual Investor Conference - Stock Titan
Iridex study shows MicroPulse laser retreatment effective for glaucoma - Investing.com
Iridex study shows MicroPulse laser retreatment effective for glaucoma By Investing.com - Investing.com Canada
Iridex Corporation Announces Positive Findings on MicroPulse Technology for Glaucoma Retreatment in Independent Study - Quiver Quantitative
Iridex Announces the Publication of an Independent Study Demonstrating Safe and Effective Retreatment with Transscleral Laser Treatment Using MicroPulse® Technology in Glaucoma Management - The Manila Times
Iridex (IRIX) Reveals Study on Laser Treatments for Glaucoma - GuruFocus
Iridex Corporation Announces Publication of Study on Thermal Dynamics of Laser Treatments for Glaucoma - Quiver Quantitative
Iridex Announces New Thermal Dynamics Study That Strengthens Clinical Foundation and Market Potential of MicroPulse® Technology and Continuous-Wave Laser for Glaucoma Treatment - marketscreener.com
Iridex (NASDAQ: IRIX) publishes thermal modeling study on MicroPulse vs CW glaucoma lasers - Stock Titan
Iridex (Nasdaq: IRIX) sets Dec. 11 slot at Sidoti virtual investor conference - Stock Titan
Is IRIDEX Corporation stock vulnerable to regulatory risksJuly 2025 Action & AI Enhanced Trading Signals - Newser
Iridex (IRIX) Stock Analysis Report | Financials & Insights - Benzinga
Iridex CFO Dizon buys $5529 in company stock By Investing.com - Investing.com Australia
Iridex CFO Dizon buys $5529 in company stock - Investing.com India
Iridex CFO Dizon buys $960 in company stock By Investing.com - Investing.com South Africa
Iridex CFO Dizon buys $960 in company stock - Investing.com
Iridex Corp (IRIX) 財務データ
収益
当期純利益
現金流量
EPS
Iridex Corp (IRIX) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Dizon Romeo R | Chief Financial Officer |
Jan 23 '26 |
Buy |
1.48 |
5,221 |
7,716 |
105,661 |
| Dizon Romeo R | Chief Financial Officer |
Jan 21 '26 |
Buy |
1.50 |
2,159 |
3,233 |
100,440 |
| Dizon Romeo R | Chief Financial Officer |
Jan 20 '26 |
Buy |
1.50 |
2,100 |
3,147 |
98,281 |
| Dizon Romeo R | Chief Financial Officer |
Jan 16 '26 |
Buy |
1.43 |
3,496 |
5,006 |
96,181 |
| MOORE WILLIAM M | Director |
Dec 16 '25 |
Buy |
1.01 |
2,000 |
2,020 |
251,550 |
| Dizon Romeo R | Chief Financial Officer |
Dec 12 '25 |
Buy |
0.97 |
2,365 |
2,296 |
92,685 |
| Dizon Romeo R | Chief Financial Officer |
Dec 02 '25 |
Buy |
0.95 |
1,584 |
1,498 |
90,320 |
| Dizon Romeo R | Chief Financial Officer |
Nov 20 '25 |
Buy |
0.96 |
5,760 |
5,530 |
88,736 |
| Dizon Romeo R | Chief Financial Officer |
Nov 19 '25 |
Buy |
0.96 |
1,000 |
960 |
82,976 |
| Dizon Romeo R | Chief Financial Officer |
Nov 18 '25 |
Buy |
0.94 |
2,133 |
2,005 |
81,976 |
2.98%
0.25%
大文字化:
|
ボリューム (24 時間):